Huron Consulting Group (HURN) Competitors

Huron Consulting Group (NASDAQ:HURN) and Apollo Medical (NASDAQ:AMEH) are both mid-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, community ranking, earnings, profitability, valuation, institutional ownership and risk.

Does the MarketBeat Community prefer HURN or AMEH?

Huron Consulting Group received 272 more outperform votes than Apollo Medical when rated by MarketBeat users. Likewise, 67.43% of users gave Huron Consulting Group an outperform vote while only 60.79% of users gave Apollo Medical an outperform vote.

Company	Underperform	Outperform
Huron Consulting Group	Outperform Votes 410 67.43%	Underperform Votes 198 32.57%
Apollo Medical	Outperform Votes 138 60.79%	Underperform Votes 89 39.21%

Does the media prefer HURN or AMEH?

In the previous week, Huron Consulting Group had 4 more articles in the media than Apollo Medical. MarketBeat recorded 4 mentions for Huron Consulting Group and 0 mentions for Apollo Medical. Huron Consulting Group's average media sentiment score of 1.24 beat Apollo Medical's score of 0.88 indicating that Huron Consulting Group is being referred to more favorably in the media.

Company	Overall Sentiment
Huron Consulting Group	Positive
Apollo Medical	Positive

Which has more volatility & risk, HURN or AMEH?

Huron Consulting Group has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Apollo Medical has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500.

Do analysts prefer HURN or AMEH?

Huron Consulting Group presently has a consensus price target of $133.00, suggesting a potential upside of 10.32%. Apollo Medical has a consensus price target of $47.75, suggesting a potential upside of 16.98%. Given Apollo Medical's higher possible upside, analysts clearly believe Apollo Medical is more favorable than Huron Consulting Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Huron Consulting Group	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Apollo Medical	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Is HURN or AMEH more profitable?

Huron Consulting Group has a net margin of 5.80% compared to Apollo Medical's net margin of 3.56%. Huron Consulting Group's return on equity of 21.51% beat Apollo Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Huron Consulting Group	5.80%	21.51%	8.38%
Apollo Medical	3.56%	9.90%	5.51%

Which has better earnings & valuation, HURN or AMEH?

Huron Consulting Group has higher revenue and earnings than Apollo Medical. Huron Consulting Group is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Huron Consulting Group	$1.40B	1.53	$62.48M	$4.60	26.21
Apollo Medical	$1.14B	2.08	$45.17M	$1.00	40.82

Do institutionals and insiders hold more shares of HURN or AMEH?

93.9% of Huron Consulting Group shares are held by institutional investors. Comparatively, 35.9% of Apollo Medical shares are held by institutional investors. 2.0% of Huron Consulting Group shares are held by insiders. Comparatively, 8.5% of Apollo Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Huron Consulting Group beats Apollo Medical on 13 of the 18 factors compared between the two stocks.